A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin [3]

Tomonori Hada; Mikio Mikami; Yoshiko Kuwabara; Kyoko Tanaka; Mituya Ishikawa; Shinichi Komiyama; Takanori Hirose

doi:10.1016/j.ejogrb.2004.02.020

A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin [3]

Tomonori Hada, Mikio Mikami, Yoshiko Kuwabara, Kyoko Tanaka, Mituya Ishikawa, Shinichi Komiyama, Takanori Hirose

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	242-243
Number of pages	2
Journal	European Journal of Obstetrics and Gynecology and Reproductive Biology
Volume	116
Issue number	2
DOIs	https://doi.org/10.1016/j.ejogrb.2004.02.020
Publication status	Published - 2004 Oct 15
Externally published	Yes

ASJC Scopus subject areas

Reproductive Medicine
Obstetrics and Gynaecology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejogrb.2004.02.020

Cite this

Hada, T., Mikami, M., Kuwabara, Y., Tanaka, K., Ishikawa, M., Komiyama, S., & Hirose, T. (2004). A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin [3]. European Journal of Obstetrics and Gynecology and Reproductive Biology, 116(2), 242-243. https://doi.org/10.1016/j.ejogrb.2004.02.020

A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin [3]. / Hada, Tomonori; Mikami, Mikio; Kuwabara, Yoshiko et al.
In: European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 116, No. 2, 15.10.2004, p. 242-243.

Research output: Contribution to journal › Letter › peer-review

Hada, T, Mikami, M, Kuwabara, Y, Tanaka, K, Ishikawa, M, Komiyama, S & Hirose, T 2004, 'A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin [3]', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 116, no. 2, pp. 242-243. https://doi.org/10.1016/j.ejogrb.2004.02.020

@article{e8f18d19e646419bb56480b19af4f5ed,

title = "A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin [3]",

author = "Tomonori Hada and Mikio Mikami and Yoshiko Kuwabara and Kyoko Tanaka and Mituya Ishikawa and Shinichi Komiyama and Takanori Hirose",

year = "2004",

month = oct,

day = "15",

doi = "10.1016/j.ejogrb.2004.02.020",

language = "English",

volume = "116",

pages = "242--243",

journal = "European Journal of Obstetrics and Gynecology and Reproductive Biology",

issn = "0301-2115",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin [3]

AU - Hada, Tomonori

AU - Mikami, Mikio

AU - Kuwabara, Yoshiko

AU - Tanaka, Kyoko

AU - Ishikawa, Mituya

AU - Komiyama, Shinichi

AU - Hirose, Takanori

PY - 2004/10/15

Y1 - 2004/10/15

UR - http://www.scopus.com/inward/record.url?scp=4444328468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444328468&partnerID=8YFLogxK

U2 - 10.1016/j.ejogrb.2004.02.020

DO - 10.1016/j.ejogrb.2004.02.020

M3 - Letter

C2 - 15358478

AN - SCOPUS:4444328468

SN - 0301-2115

VL - 116

SP - 242

EP - 243

JO - European Journal of Obstetrics and Gynecology and Reproductive Biology

JF - European Journal of Obstetrics and Gynecology and Reproductive Biology

IS - 2

ER -

A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin [3]

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this